These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30650980)

  • 1. Hormonal contraception used by adolescents and the risk of thromboembolic disease.
    Havlín M
    Cas Lek Cesk; 2018 Dec; 157(7):358-362. PubMed ID: 30650980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonal contraception for adolescents? (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1978 Sep; 120(37):1193-8. PubMed ID: 308178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug and food interactions with contraceptives: CNGOF Contraception Guidelines].
    Bernier M; Jonville-Bera AP
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):786-791. PubMed ID: 30385357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.
    Gourdy P; Bachelot A; Catteau-Jonard S; Chabbert-Buffet N; Christin-Maître S; Conard J; Fredenrich A; Gompel A; Lamiche-Lorenzini F; Moreau C; Plu-Bureau G; Vambergue A; Vergès B; Kerlan V
    Ann Endocrinol (Paris); 2012 Nov; 73(5):469-87. PubMed ID: 23078975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to planned and unplanned pregnancies.
    Rosenfeld JA; Everett KD
    J Fam Pract; 1996 Aug; 43(2):161-6. PubMed ID: 8708626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraception in the adolescent patient.
    Tafelski T; Boehm KE
    Prim Care; 1995 Mar; 22(1):145-59. PubMed ID: 7777635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal contraception--throboembolism and surgical risk].
    Göretzlehner G; Frick G; Frick U
    Zentralbl Gynakol; 1976; 98(10):600-10. PubMed ID: 961166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed hormonal contraceptives: new recommendations.
    Guilbert E; Black A; Dunn S; Senikas V; ;
    J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception for adolescent : CNGOF Contraception guidelines].
    Pienkowski C; Cartault A
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):858-864. PubMed ID: 30392989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
    Gourbil M; Grandvuillemin A; Beyens MN; Massy N; Gras V; D'Amico A; Miremont-Salamé G; Petitpain N;
    Drug Saf; 2014 Apr; 37(4):269-82. PubMed ID: 24634164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
    Bhakta J; Bainbridge J; Borgelt L
    Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal contraception and thrombosis.
    Sitruk-Ware R
    Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing young women's decision making regarding hormonal contraceptives: a qualitative study.
    Cheung E; Free C
    Contraception; 2005 Jun; 71(6):426-31. PubMed ID: 15914131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?
    Drife J
    Drug Saf; 2002; 25(13):893-902. PubMed ID: 12381211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraception in thrombophilic adolescents: risk of thrombosis and recommendations.
    Rott H
    Hamostaseologie; 2012; 32(1):15-21. PubMed ID: 22009044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
    Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
    Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal contraception and thromboembolic disease. I. Epidemiologic data].
    Paseka J; Unzeitig V
    Ceska Gynekol; 1997 Apr; 62(2):75-8. PubMed ID: 9296797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.